KR930701193A - 단클론성 항체의 신규한 용도 - Google Patents

단클론성 항체의 신규한 용도

Info

Publication number
KR930701193A
KR930701193A KR1019930700386A KR930700386A KR930701193A KR 930701193 A KR930701193 A KR 930701193A KR 1019930700386 A KR1019930700386 A KR 1019930700386A KR 930700386 A KR930700386 A KR 930700386A KR 930701193 A KR930701193 A KR 930701193A
Authority
KR
South Korea
Prior art keywords
monoclonal antibody
specificity
fragment
variant
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019930700386A
Other languages
English (en)
Korean (ko)
Inventor
로이브너 한스
Original Assignee
쟝 크라머, 한스 루돌프 하우스
산도즈 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 쟝 크라머, 한스 루돌프 하우스, 산도즈 리미티드 filed Critical 쟝 크라머, 한스 루돌프 하우스
Publication of KR930701193A publication Critical patent/KR930701193A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1019930700386A 1990-08-11 1991-08-08 단클론성 항체의 신규한 용도 Withdrawn KR930701193A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4025499A DE4025499A1 (de) 1990-08-11 1990-08-11 Verwendung der antikoerper br55-2, deren derivate, konjugate und fragmente zur bekaempfung von hiv-infektionen
DEP4025499.2 1990-08-11
PCT/EP1991/001510 WO1992003165A1 (en) 1990-08-11 1991-08-08 New use of a monoclonal antibody

Publications (1)

Publication Number Publication Date
KR930701193A true KR930701193A (ko) 1993-06-11

Family

ID=6412074

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930700386A Withdrawn KR930701193A (ko) 1990-08-11 1991-08-08 단클론성 항체의 신규한 용도

Country Status (13)

Country Link
EP (1) EP0547079B1 (https=)
JP (1) JPH06500771A (https=)
KR (1) KR930701193A (https=)
AT (1) ATE136469T1 (https=)
AU (1) AU657489B2 (https=)
CA (1) CA2088370C (https=)
DE (2) DE4025499A1 (https=)
HU (1) HUT64238A (https=)
IE (1) IE912823A1 (https=)
PT (1) PT98622A (https=)
TW (1) TW223019B (https=)
WO (1) WO1992003165A1 (https=)
ZA (1) ZA916313B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69230545T2 (de) * 1991-08-21 2000-07-06 Novartis Ag, Basel Antikörperderivate
PL175651B1 (pl) * 1992-05-22 1999-01-29 Novartis Ag Antyidiotypowe mysie przeciwciała monoklonalne oraz sposób wytwarzania antyidiotypowych przeciwciał monoklonalnych
ATE249846T1 (de) * 1998-06-29 2003-10-15 Wolfgang Bergter Antivirale und antiretrovirale radioimmunpharmaka auf der basis von alpha- und beta-strahlern

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU592142B2 (en) * 1985-11-25 1990-01-04 Cytogen Corporation Modified viral glycoproteins, diagnostic and therapeutic uses therefore
JPH083487B2 (ja) * 1987-07-31 1996-01-17 株式会社日本抗体研究所 異常応答リンパ球の検出方法並びにこれに用いる検出用試薬及びキット

Also Published As

Publication number Publication date
HU9300349D0 (en) 1993-05-28
JPH06500771A (ja) 1994-01-27
WO1992003165A1 (en) 1992-03-05
DE4025499A1 (de) 1992-02-13
CA2088370C (en) 2003-03-25
AU657489B2 (en) 1995-03-16
EP0547079B1 (en) 1996-04-10
HUT64238A (en) 1993-12-28
DE69118702D1 (de) 1996-05-15
CA2088370A1 (en) 1992-02-12
ZA916313B (en) 1993-04-28
DE69118702T2 (de) 1996-09-05
AU8393291A (en) 1992-03-17
IE912823A1 (en) 1992-02-12
TW223019B (https=) 1994-05-01
EP0547079A1 (en) 1993-06-23
ATE136469T1 (de) 1996-04-15
PT98622A (pt) 1992-06-30

Similar Documents

Publication Publication Date Title
Mady et al. Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fc gamma receptors
CO4850562A1 (es) Proceso para producir una preparacion concentrada de anticuerpos
ES2102347T3 (es) Metodos y composiciones para la utilizacion de polipeptidos env y anticuerpos anti-env de hiv.
US5834599A (en) Immunoconjugates which neutralize HIV-1 infection
WO1991003493A1 (en) Bi-or trispecific (fab)3 or (fab)4 conjugates
AU561660B2 (en) Conjugate of ricin chain a and monoclonal antibody
WO1990010457A1 (en) Method of treating hiv infections using immunotoxins
US6140043A (en) Pharmaceutical compositions for competitively inhibiting the binding of a retrovirus to the IFN-receptor and means for diagnosis of an HIV infection
RU2011130522A (ru) Моноклональное антитело против hcv в качестве лекарственного средства для терапевтического лечения и профилактики инфекций hcv
KR930701193A (ko) 단클론성 항체의 신규한 용도
DE69227500D1 (de) In der Therapie von einer HIV-1-Infektion verwendbare monoklonale Antikörper
BRPI9709524B8 (pt) processo para a produção de um anticorpo para células t que expressam cd4
Derocq et al. Comparison of the cytotoxic potency of T101 Fab, F (ab') 2 and whole IgG immunotoxins.
Van Dixhoorn et al. Combined glomerular deposition of polymeric rat IgA and IgG aggravates renal inflammation
Kim et al. Immunoconjugates that neutralize HIV virions kill T cells infected with diverse strains of HIV-1.
TR200102506T2 (tr) Ige'nin C-epsilon-2 alanından türetilmiş epitoplar veya mimotoplar
ES2000615A6 (es) Procedimiento para la preparacion del anticuerpo monoclonal designado como mak 436-15 del isotipo igg3"
Chen et al. The human monocyte cell line U937 binds HIV-1 gp41 by proteins of 37, 45, 49, 62 and 92 kDa
WO1990009805A1 (en) Human monoclonal antibodies to human immunodeficiency virus
PT92071A (pt) Processo de preparacao de imunotoxinas e de preparados farmaceuticos para o tratamento ou profilaxia de doencas auto-imunes
Silvestris et al. Molecular specificities of CD4+ T cell-reactive IgM in human immunodeficiency virus (HIV-1) infection
CA2606022A1 (en) Methods of applying ionization radiation for therapy of hiv infection
KR890010191A (ko) 만손주혈흡충에 대한 백신
Chiang et al. Collagen-platelet interaction: Inhibition by a monoclonal antibody which binds a 90,000 dalton platelet glycoprotein
Gershoni The use of CD4/GP120 Interactions in the Development of Anti-HIV Drugs and Vaccines.

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19930210

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid